Advanced MR Imaging of Gliomas: an Update

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Jul 18

PMID 23862163

Citations 32

Authors

Hung-Wen Kao

Shih-Wei Chiang

Hsiao-Wen Chung

Fong Y Tsai

Cheng-Yu Chen

Affiliations

Soon will be listed here.

Abstract

Recent advances in the treatment of cerebral gliomas have increased the demands on noninvasive neuroimaging for the diagnosis, therapeutic planning, tumor monitoring, and patient outcome prediction. In the meantime, improved magnetic resonance (MR) imaging techniques have shown much potentials in evaluating the key pathological features of the gliomas, including cellularity, invasiveness, mitotic activity, angiogenesis, and necrosis, hence, further shedding light on glioma grading before treatment. In this paper, an update of advanced MR imaging techniques is reviewed, and their potential roles as biomarkers of tumor grading are discussed.

Citing Articles

Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.

Wang X, Shu X, He P, Cai Y, Geng Y, Hu X Eur Radiol. 2024; 34(10):6751-6762.

PMID: 38528135 DOI: 10.1007/s00330-024-10708-5.

Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.

Alshahrany N, Begum A, Siebzehnrubl D, Jimenez-Pascual A, Siebzehnrubl F Cancer Lett. 2023; 571:216349.

PMID: 37579831 PMC: 10840508. DOI: 10.1016/j.canlet.2023.216349.

Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI.

Nunez-Gonzalez L, van Garderen K, Smits M, Jaspers J, Mendez Romero A, Poot D Sci Rep. 2022; 12(1):21820.

PMID: 36528673 PMC: 9759533. DOI: 10.1038/s41598-022-24276-5.

Role of Magnetic Resonance Imaging (MRI) in grading gliomas comparable with pathology: A cross-sectional study from Syria.

Haydar N, Alyousef K, Alanan U, Issa R, Baddour F, Al-Shehabi Z Ann Med Surg (Lond). 2022; 82:104679.

PMID: 36268388 PMC: 9577635. DOI: 10.1016/j.amsu.2022.104679.

Differentiation of malignant brain tumor types using intratumoral and peritumoral radiomic features.

Liu D, Chen J, Ge H, Hu X, Yang K, Liu Y Front Oncol. 2022; 12:848846.

PMID: 35965511 PMC: 9366472. DOI: 10.3389/fonc.2022.848846.

References

Reifenberger G, Collins V . Pathology and molecular genetics of astrocytic gliomas. J Mol Med (Berl). 2004; 82(10):656-70. DOI: 10.1007/s00109-004-0564-x. View

Sugahara T, Korogi Y, Kochi M, Ikushima I, SHIGEMATU Y, Hirai T . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999; 9(1):53-60. DOI: 10.1002/(sici)1522-2586(199901)9:1<53::aid-jmri7>3.0.co;2-2. View

Curran Jr W, Scott C, Horton J, Nelson J, Weinstein A, Fischbach A . Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993; 85(9):704-10. DOI: 10.1093/jnci/85.9.704. View

Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent M . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008; 9(5):453-61. DOI: 10.1016/S1470-2045(08)70125-6. View

Chiang I, Hsieh T, Chiu M, Liu G, Kuo Y, Lin W . Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging. Br J Radiol. 2009; 82(982):813-20. DOI: 10.1259/bjr/90100265. View

Cao Y, Sundgren P, Tsien C, Chenevert T, Junck L . Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol. 2006; 24(8):1228-35. DOI: 10.1200/JCO.2005.04.7233. View

Remy C, Fouilhe N, Barba I, Lahrech H, Cucurella M, Izquierdo M . Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res. 1997; 57(3):407-14. View

Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre P, Franceschi S . Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol. 2006; 65(9):846-54. DOI: 10.1097/01.jnen.0000235118.75182.94. View

Sadeghi N, Salmon I, Decaestecker C, Levivier M, Metens T, Wikler D . Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol. 2007; 28(3):455-61. PMC: 7977817. View

10.

Ashrafpour H, Huang N, Neligan P, Forrest C, Addison P, Moses M . Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol. 2003; 286(3):H946-54. DOI: 10.1152/ajpheart.00901.2003. View

11.

Kleihues P, Ohgaki H . Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol. 2001; 1(1):44-51. PMC: 1919466. DOI: 10.1093/neuonc/1.1.44. View

12.

Hacklander T, Reichenbach J, Hofer M, Modder U . Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit. AJNR Am J Neuroradiol. 1996; 17(5):821-30. PMC: 8337506. View

13.

Lu S, Ahn D, Johnson G, Cha S . Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol. 2003; 24(5):937-41. PMC: 7975803. View

14.

Castillo M, Smith J, Kwock L . Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol. 2000; 21(9):1645-9. PMC: 8174883. View

15.

Li K, Zhu X, Checkley D, Tessier J, Hillier V, Waterton J . Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol. 2003; 76(901):39-50. DOI: 10.1259/bjr/31662734. View

16.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ambros P . Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol. 2003; 13(2):133-43. PMC: 8095831. DOI: 10.1111/j.1750-3639.2003.tb00013.x. View

17.

Freije W, Castro-Vargas F, Fang Z, Horvath S, Cloughesy T, Liau L . Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004; 64(18):6503-10. DOI: 10.1158/0008-5472.CAN-04-0452. View

18.

Machein M, Plate K . VEGF in brain tumors. J Neurooncol. 2001; 50(1-2):109-20. DOI: 10.1023/a:1006416003964. View

19.

Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre P . Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004; 64(19):6892-9. DOI: 10.1158/0008-5472.CAN-04-1337. View

20.

Noguchi K, Watanabe N, Nagayoshi T, Kanazawa T, Toyoshima S, Shimizu M . Role of diffusion-weighted echo-planar MRI in distinguishing between brain brain abscess and tumour: a preliminary report. Neuroradiology. 1999; 41(3):171-4. DOI: 10.1007/s002340050726. View